logo
Select company
Select metric
-94206.33%EBITDA Margin
VS
Market
1
Sector
2
Industry
4
History
-
$ 3.33Close
$ 1.8 - $ 6.45 52-Week Range
Ticker Information

Ticker

CELZ

Company Name

CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CELZ - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -5.65M-94206.33%$ 6K
3/31/2025$ -5.98M-42701.97%$ 14K
12/31/2024$ -5.38M-48936.63%$ 11K
9/30/2024$ -5.2M-47314.97%$ 11K
6/30/2024$ -5.62M-33086.55%$ 17K
3/31/2024$ -5.18M-57504.01%$ 9K
12/31/2023$ -5.19M-57688.78%$ 9K
9/30/2023$ -9.73M-39559.18%$ 24.6K
6/30/2023$ -9.26M-12581.45%$ 73.6K
3/31/2023$ -9.95M-13517.61%$ 73.6K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC's latest trailing twelve months (TTM) EBITDA % stands at -21294.13%.
  • Over the past 5 years, CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC's average EBITDA % has been -27543.57%.
  • The median EBITDA % for CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC during this period was -21294.13%
  • CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC reached its highest EBITDA % over the past 5 years at 26873.17%.
  • The lowest EBITDA % recorded by CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC in the same timeframe -94206.33%

CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
IBO : IMPACT BIOMEDICAL INC -517200%HSCS : HEARTSCIENCES INC -127689.7%TCRT : ALAUNOS THERAPEUTICS INC -99850%OSRH : OSR HOLDINGS INC -363.64%ADIL : ADIAL PHARMACEUTICALS INC -MTNB : MATINAS BIOPHARMA HOLDINGS INC -TSBX : TURNSTONE BIOLOGICS CORP -KPRX : KIORA PHARMACEUTICALS INC -DWTX : DOGWOOD THERAPEUTICS INC -RNAZ : TRANSCODE THERAPEUTICS INC -

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC is calculated as follows: EBITDA [ $ -35.03M ] / Revenues [ $ 164.5K ]
(=) EBITDA % [ -21294.13% ]

CELZ - EBITDA Margin, Last 5 years

-94206.33%

Minimum

Jun 30, 2025

26873.17%

Maximum

Dec 31, 2021

-27543.57%

Average

-21294.13%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%